PCLYFEG Stock Latest News
Private CompaniesCMS Reporting Review Highlights Data Needs in Value-Based Medicaid Rebates1w agoLYFEG
Private CompaniesLyfegen Highlights Cross-Market Agreement Management Challenges1w agoLYFEG
Private CompaniesMedicaid Pharmacy Cost Controls Signal Opportunity for Lyfegen Analytics2w agoLYFEG- Private CompaniesLifecycle Management Focus Highlights Lyfegen’s Drug Contracting Opportunity3w agoLYFEG
Private CompaniesLyfegen Highlights Focus on Canadian Market Access and Reimbursement Engagement4w agoLYFEG
Private CompaniesLyfegen Targets Opportunity in Complex Canadian Market Access Landscape4w agoLYFEG
Private CompaniesLyfegen Engages in European Policy Dialogue on Drug Pricing and Market Access1M agoLYFEG
Private CompaniesLyfegen Steps Up Global Push in Value-Based Drug Contracting and Market Access1M agoLYFEG
Private CompaniesLyfegen Highlights Role in Scaling Value-Based Drug Contract Execution1M agoLYFEG- Private CompaniesLyfegen Highlights Role in Value-Based Market Access Summit1M agoLYFEG
Private CompaniesLyfegen – Weekly Recap1M agoLYFEGPrivate CompaniesLyfegen Executives Engage With Medicaid Stakeholders at NASHP Conference1M agoLYFEG
Private CompaniesLyfegen Engages in Swiss Healthcare Policy Dialogue on Cost Pressure and Rebates1M agoLYFEG- Private CompaniesParticipation in Ontario Forum Highlights Focus on Drug Access and Pricing Dynamics1M agoLYFEG
- Private CompaniesLyfegen – Weekly Recap2M agoLYFEG
- Private CompaniesRebate Governance Positioned as Strategic Capability in Drug Contracting2M agoLYFEG
Private CompaniesLyfegen – Weekly Recap2M agoLYFEGPrivate CompaniesLyfegen Positions Drug Value Management to Address European Market Access Gaps2M agoLYFEG